Talacotuzumab Uses, Dosage, Side Effects and more
Talacotuzumab is under investigation in clinical trial NCT01632852 (A Study of CSL362 in Patients With CD123+ Acute Myeloid Leukemia Currently in Remission).
| Attribute | Details |
|---|---|
| Trade Name | Talacotuzumab |
| Generic | Talacotuzumab |
| Talacotuzumab Other Names | Talacotuzumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
